| Product Code: ETC6739207 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cellular Immunotherapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cellular Immunotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 China Cellular Immunotherapy Market - Industry Life Cycle |
3.4 China Cellular Immunotherapy Market - Porter's Five Forces |
3.5 China Cellular Immunotherapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 China Cellular Immunotherapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 China Cellular Immunotherapy Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 China Cellular Immunotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing investments in research and development of cellular immunotherapy |
4.2.3 Favorable government initiatives and policies to support the adoption of cellular immunotherapy |
4.3 Market Restraints |
4.3.1 High cost associated with cellular immunotherapy treatments |
4.3.2 Limited awareness and understanding of cellular immunotherapy among healthcare providers and patients |
4.3.3 Stringent regulatory requirements for approval of cellular immunotherapy products in China |
5 China Cellular Immunotherapy Market Trends |
6 China Cellular Immunotherapy Market, By Types |
6.1 China Cellular Immunotherapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 China Cellular Immunotherapy Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 China Cellular Immunotherapy Market Revenues & Volume, By CAR T Cell Therapy, 2021- 2031F |
6.1.4 China Cellular Immunotherapy Market Revenues & Volume, By Dendritic Cell Therapy, 2021- 2031F |
6.1.5 China Cellular Immunotherapy Market Revenues & Volume, By NK Cell Therapy, 2021- 2031F |
6.1.6 China Cellular Immunotherapy Market Revenues & Volume, By TIL Therapy, 2021- 2031F |
6.1.7 China Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Cellular Immunotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Cellular Immunotherapy Market Revenues & Volume, By B-cell Malignancies, 2021- 2031F |
6.2.3 China Cellular Immunotherapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.4 China Cellular Immunotherapy Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.5 China Cellular Immunotherapy Market Revenues & Volume, By Renal Cell Carcinoma, 2021- 2031F |
6.2.6 China Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Cellular Immunotherapy Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 China Cellular Immunotherapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Cellular Immunotherapy Market Revenues & Volume, By Cancer Institutes, 2021- 2031F |
6.3.4 China Cellular Immunotherapy Market Revenues & Volume, By Others, 2021- 2031F |
7 China Cellular Immunotherapy Market Import-Export Trade Statistics |
7.1 China Cellular Immunotherapy Market Export to Major Countries |
7.2 China Cellular Immunotherapy Market Imports from Major Countries |
8 China Cellular Immunotherapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies related to cellular immunotherapy in China |
8.2 Adoption rate of cellular immunotherapy treatments in major cities |
8.3 Number of partnerships and collaborations between Chinese biotech companies and international pharmaceutical firms in the cellular immunotherapy space |
9 China Cellular Immunotherapy Market - Opportunity Assessment |
9.1 China Cellular Immunotherapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 China Cellular Immunotherapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 China Cellular Immunotherapy Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 China Cellular Immunotherapy Market - Competitive Landscape |
10.1 China Cellular Immunotherapy Market Revenue Share, By Companies, 2024 |
10.2 China Cellular Immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here